Description

This issue of Vital Signs, released on October 26, 2009, provides strategic overview of changes in the histopathology market. Additionally, a company spotlight is provided for Celerus Diagnostics, an emerging company dedicated to the development and commercialization of innovative technological solutions, the enhancement of the diagnostic capabilities of the anatomic pathology laboratory, and providing clinicians with rapid, reliable, actionable diagnostic information and advancing patient care. Reimbursement and regulatory news from the FDA is also provided for the week of October 13, 2009.